User login
Article Type
Changed
Thu, 12/15/2022 - 18:23
Display Headline
Bisphosphonates as Antitumor Agents in Breast Cancer
SAN ANTONIO – Dr. Hope S. Rugo, associate editor of The Oncology Report, discusses the use of bisphosphonates as antitumor agents in early-stage breast cancer at the 2011 San Antonio Breast Cancer Symposium.
Topics
Legacy Keywords
bisphosphonates, anti-tumor agents, early-stage breast cancer, bisphosphonates breast cancer, Dr. Hope S. Rugo
SAN ANTONIO – Dr. Hope S. Rugo, associate editor of The Oncology Report, discusses the use of bisphosphonates as antitumor agents in early-stage breast cancer at the 2011 San Antonio Breast Cancer Symposium.
SAN ANTONIO – Dr. Hope S. Rugo, associate editor of The Oncology Report, discusses the use of bisphosphonates as antitumor agents in early-stage breast cancer at the 2011 San Antonio Breast Cancer Symposium.
Topics
Article Type
Display Headline
Bisphosphonates as Antitumor Agents in Breast Cancer
Display Headline
Bisphosphonates as Antitumor Agents in Breast Cancer
Legacy Keywords
bisphosphonates, anti-tumor agents, early-stage breast cancer, bisphosphonates breast cancer, Dr. Hope S. Rugo
Legacy Keywords
bisphosphonates, anti-tumor agents, early-stage breast cancer, bisphosphonates breast cancer, Dr. Hope S. Rugo
Article Source
PURLs Copyright
Inside the Article